Annotation Detail for SLC16A9
Basic Information
Top
| Gene Symbol: | SLC16A9 ( C10orf36,FLJ43803,MCT9 ) |
|---|
| Gene Full Name: | solute carrier family 16, member 9 (monocarboxylic acid transporter 9) |
|---|
| Band: | 10q21.2 |
|---|
| Quick Links | Entrez ID:220963; OMIM: NA; Uniprot ID:MOT9_HUMAN; ENSEMBL ID: ENSG00000165449; HGNC ID: 23520 |
|---|
| Relate to Another Database: |
SFARIGene;
denovo-db |
| Desease Name |
|---|
| serum uric acid |
| METABOLIC |
| Desease Name |
|---|
| Serum uric acid |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of SLC16A9 mRNA | increases expression | 19933214
|
| C015001 |
arsenite |
arsenite results in decreased expression of SLC16A9 mRNA | decreases expression | 18929588
|
| C015001 |
arsenite |
TRP53 protein affects the reaction [arsenite results in decreased expression of SLC16A9 mRNA] | affects reaction|decreases expression | 18929588
|
| D019301 |
Oleic Acid |
PPARA protein promotes the reaction [Oleic Acid results in decreased expression of SLC16A9 mRNA] | decreases expression|increases reaction | 18489776
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of SLC16A9 mRNA | increases expression | 19933214
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.47 | 14514962 15322242 11752688 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
4.01 | 16835633 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.34 | 11748828 |
| MESH:D000860 |
Anoxia |
|
Oleic Acid |
6.52 | 15090967 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.47 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.51 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
3.00 | 15746008 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.67 | 20435547 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.12 | 16835633 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.56 | 16120746 18850075 18670907 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.24 | 16354765 12621046 15668235 15340226 8697196 |
| MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
2.63 | 15037631 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.43 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.27 | 15322242 10048152 20055451 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.74 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.62 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
3.05 | 11462148 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.80 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.62 | 16714409 18230668 15322242 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.42 | 9294722 10568697 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
arsenite |
4.20 | 18296743 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
4.02 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
arsenite |
10.76 | 18296743 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
10.76 | 20067830 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.32 | 10696789 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.51 | 11294989 10048152 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.76 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.45 | 15340226 12621046 16120746 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.77 | 16959395 16354765 8697196 18606429 15340226 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.02 | 18670907 18850075 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
2.03 | 12200463 12878042 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.76 | 16580747 |
| MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.61 | 18296743 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.25 | 12878042 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.83 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.33 | 12151625 |
| MESH:D055370 |
Lung Injury |
|
Oleic Acid |
5.91 | 15090967 |
| MESH:D008175 |
Lung Neoplasms |
|
arsenite |
2.56 | 16809336 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.56 | 11884234 19555203 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.34 | 12213967 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
5.04 | 15738583 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.72 | 14600291 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.97 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
4.07 | 18163543 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.82 | 11896295 11399792 11118676 11222880 |
| MESH:D011654 |
Pulmonary Edema |
|
Oleic Acid |
6.52 | 15090967 |
| MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oleic Acid |
5.81 | 18549715 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.35 | 18990726 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.20 | 16192470 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.62 | 12697716 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.32 | 12125929 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.97 | 15886252 |
Related Pathway Information